TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st October 2019, due to Assembly Elections in Maharashtra.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3%
Mon, 6 Aug

TORRENT PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m13,74017,22018,7208.7%36.2%
Other incomeRs m1,050420270-35.7%-74.3%
TurnoverRs m14,79017,64018,9907.7%28.4%
ExpensesRs m10,77013,58013,9502.7%29.5%
Gross profitRs m2,9703,6404,77031.0%60.6%
DepreciationRs m8001,5101,500-0.7%87.5%
InterestRs m5601,2101,2200.8%117.9%
Profit before taxRs m2,6601,3402,32073.1%-12.8%
TaxRs m780-940690-11.5%
Profit after taxRs m1,8802,2801,630-28.5%-13.3%
Gross profit margin%21.621.125.5
Effective tax rate%29.3-70.129.7
Net profit margin%12.712.98.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 36.2% on a year-on-year (YoY) basis. The expenses were up by 29.5% YoY during the same period.
  • The company's operating profit increased by 60.6% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.5% in 1QFY19 as against 21.6% in 1QFY18.
  • Depreciation charges and finance costs increased by 87.5% YoY and 117.9% YoY, respectively.
  • Other income declined by 74.3% YoY during the quarter.
  • Net profit for the quarter declined by 13.3% YoY. Net profit margins during the quarter declined from 12.7% in 1QFY18 to 8.6% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.7% QoQ during the same period.
  • The company's operating profit increased by 31.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.5% in 1QFY19 as against 21.1% in 4QFY18.
  • Net profit for the quarter declined by 28.5% QoQ, while net profit margins declined from 12.9% in 4QFY18 to 8.6% in 1QFY19.

To see how TORRENT PHARMA has performed over the last eight quarters, please visit here.

TORRENT PHARMA Share Price Performance

Over the last one year, TORRENT PHARMA share price has moved up from Rs 1,272.8 to Rs 1,646.0, registering a Gain of Rs 373.3 or around 29.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,615.5 (down 0.4%). Over the last one year it has moved up from 13,877.8 to 14,615.5, a gain of 738 points (up 5.3%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 1,646.0, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 42.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.0 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - PFIZER COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS